Bacterial-derived biopolymers: Advanced natural nanomaterials for drug delivery and tissue engineering

TrAC - Trends in Analytical Chemistry

Volumn 82, Issue , 2016, Pages 367-384

  Mokhtarzadeh, Ahad ^a,b   Alibakhshi, Abbas ^c   Hejazi, Maryam ^d   Omidi, Yadollah ^a   Ezzati Nazhad Dolatabadi, Jafar ^a  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b HIGHER EDUCATION INSTITUTE OF RAB RASHID   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d GONABAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Biodegradable; Drug carrier; Nanomaterials; Polysaccharides; Tissue engineering

Indexed keywords

BACTERIA; BIOCOMPATIBILITY; BIODEGRADABLE POLYMERS; BIOMOLECULES; BIOPOLYMERS; FUNCTIONAL POLYMERS; NANOSTRUCTURED MATERIALS; POLYSACCHARIDES; SCAFFOLDS (BIOLOGY); TISSUE;

BIODEGRADABLE; BIODEGRADABLE BIOPOLYMERS; DELIVERY VEHICLE; DRUG CARRIER; GOOD COMPATIBILITY; PHARMACEUTICAL APPLICATIONS; PHYSICOCHEMICAL PROPERTY; THERAPEUTIC AGENTS;

TISSUE ENGINEERING;

2 HYDROXYETHYL METHACRYLATE; ALGINIC ACID; BIOPOLYMER; CARBON NANOTUBE; CARVEDILOL; CISPLATIN; CYANOPHYCIN; DEXTRAN; ERYTHROMYCIN; GELLAN; GLIPIZIDE; GOLD NANOPARTICLE; GROWTH FACTOR; LIPOSOME; METFORMIN; NANOCARRIER; NANOCOMPOSITE; NANOMATERIAL; PACLITAXEL; POLY(EPSILON LYSINE); POLY(GAMMA GLUTAMIC ACID); POLYAMIDE; POLYESTER; POLYHYDROXYALKANOIC ACID; POLYSACCHARIDE; QUANTUM DOT; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASCULOTROPIN; VIRUS VECTOR; XANTHAN;

BACTERIUM; BIOCOMPATIBILITY; BIODEGRADABILITY; BIORESORBABLE SCAFFOLD; CHEMICAL STRUCTURE; CONJUGATION; CONTROLLED DRUG RELEASE; DRUG DELIVERY SYSTEM; DRUG INDICATION; EXTRACELLULAR MATRIX; FLOW KINETICS; GENE TRANSFER; HYDROGEL; MOLECULAR WEIGHT; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; REVIEW; SAFETY; TISSUE ENGINEERING; TISSUE REGENERATION;

EID: 84977140452     PISSN: 01659936     EISSN: 18793142     Source Type: Journal    
DOI: 10.1016/j.trac.2016.06.013     Document Type: Review

References (127)

1. [1] Ezzati Nazhad Dolatabadi, J., Omidi, Y., Solid lipid-based nanocarriers as efficient targeted drug and gene delivery systems. Trends Analyt. Chem 77 (2016), 100–108.
2. [2] Jamali, A.A., Pourhassan-Moghaddam, M., Dolatabadi, J.E.N., Omidi, Y., Nanomaterials on the road to miRNA detection with optical and electrochemical nanobiosensors. Trends Analyt. Chem 55 (2014), 24–42.
3. [3] Mokhtarzadeh, A., Alibakhshi, A., Yaghoobi, H., Hashemi, M., Hejazi, M., Ramezani, M., Recent advances on biocompatible and biodegradable nanoparticles as gene carriers. Expert Opin. Biol. Ther 16 (2016), 771–785.
4. [4] Rodríguez-Carmona, E., Villaverde, A., Nanostructured bacterial materials for innovative medicines. Trends Microbiol 18 (2010), 423–430.
5. [5] Rehm, B.H., Bacterial polymers: biosynthesis, modifications and applications. Nat. Rev. Microbiol 8 (2010), 578–592.
6. [6] Vu, B., Chen, M., Crawford, R.J., Ivanova, E.P., Bacterial extracellular polysaccharides involved in biofilm formation. Molecules 14 (2009), 2535–2554.
7. [7] Heinze, T., Liebert, T., Heublein, B., Hornig, S., Functional Polymers Based on Dextran. 2006, Springer, Polysaccharides Ii, 199–291.
8. [8] Santos, M., Teixeira, J., Rodrigues, A., Production of dextransucrase, dextran and fructose from sucrose using Leuconostoc mesenteroides NRRL B512 (f). Biochem. Eng. J. 4 (2000), 177–188.
9. [9] Sun, G., Mao, J.J., Engineering dextran-based scaffolds for drug delivery and tissue repair. Nanomedicine (Lond.) 7 (2012), 1771–1784.
10. [10] Sharma, R., Sharma, C., Macromolecular drugs: novel strategy in target specific drug delivery. J. Clin. Diagn. Res 2 (2008), 1020–1023.
11. [11] Brøndsted, H., Andersen, C., Hovgaard, L., Crosslinked dextran – a new capsule material for colon targeting of drugs. J. Control. Release 53 (1998), 7–13.
12. [12] Askari, M., Fisher, C., Weniger, F.G., Bidic, S., Lee, W., Anticoagulation therapy in microsurgery: a review. J. Hand Surg. Am 31 (2006), 836–846.
13. [13] Jain, M., Matsumura, K., Dextran Based Polyampholyte Having Cryoprotective Properties, MRS Proceedings. 2013, Cambridge Univ Press, 33–38.
14. [14] Van Tomme, S.R., Hennink, W.E., Biodegradable dextran hydrogels for protein delivery applications. Expert Rev. Med. Devices 4 (2007), 147–164.
15. [15] Vijan, V., Kaity, S., Biswas, S., Isaac, J., Ghosh, A., Microwave assisted synthesis and characterization of acrylamide grafted gellan, application in drug delivery. Carbohydr. Polym 90 (2012), 496–506.
16. [16] Yu, X., Pishko, M.V., Release of paclitaxel from pH sensitive and biodegradable dextran based hydrogels. Soft Matter 7 (2011), 8898–8904.
17. [17] Zhang, H., Wu, H., Fan, L., Li, F., Gu, C.H., Jia, M., Preparation and characteristics of pH-sensitive derivated dextran hydrogel nanoparticles. Polym. Composites 30 (2009), 1243–1250.
18. [18] Sun, G., Chu, C.-C., Biodegradable nanospheres self-assembled from complementary hydrophilic dextran macromers. Carbohyd. Polym 86 (2011), 910–916.
19. [19] Luten, J., van Nostrum, C.F., De Smedt, S.C., Hennink, W.E., Biodegradable polymers as non-viral carriers for plasmid DNA delivery. J. Control. Release 126 (2008), 97–110.
20. [20] Ochrimenko, S., Vollrath, A., Tauhardt, L., Kempe, K., Schubert, S., Schubert, U.S., et al. Dextran-graft-linear poly (ethylene imine) s for gene delivery: importance of the linking strategy. Carbohydr. Polym 113 (2014), 597–606.
21. [21] Chiu, W.-J., Chen, W.-Y., Lai, H.-Z., Wu, C.-Y., Chiang, H.-L., Chen, Y.-C., Dextran-encapsulated photoluminescent gold nanoclusters: synthesis and application. J. Nanopart. Res 16 (2014), 1–11.
22. [22] Hyon, S.H., Nakajima, N., Sugai, H., Matsumura, K., Low cytotoxic tissue adhesive based on oxidized dextran and epsilon-poly-L-lysine. J. Biomed. Mater. Res. A 102 (2014), 2511–2520.
23. [23] Sun, G., Shen, Y.-I., Kusuma, S., Fox-Talbot, K., Steenbergen, C.J., Gerecht, S., Functional neovascularization of biodegradable dextran hydrogels with multiple angiogenic growth factors. Biomaterials 32 (2011), 95–106.
24. [24] Wang, T., Nie, J., Yang, D., Dextran and gelatin based photocrosslinkable tissue adhesive. Carbohydr. Polym 90 (2012), 1428–1436.
25. [25] Aziz, M.A., Cabral, J.D., Brooks, H.J., McConnell, M.A., Fitzpatrick, C., Hanton, L.R., et al. In vitro biocompatibility and cellular interactions of a chitosan/dextran-based hydrogel for postsurgical adhesion prevention. J. Biomed. Mater. Res. B. Appl Biomater 103:2 (2015), 332–341.
26. [26] Matsumura, K., Nakajima, N., Sugai, H., Hyon, S.-H., Self-degradation of tissue adhesive based on oxidized dextran and poly-l-lysine. Carbohydr. Polym 113 (2014), 32–38.
27. [27] Pawar, S.N., Edgar, K.J., Alginate derivatization: a review of chemistry, properties and applications. Biomaterials 33 (2012), 3279–3305.
28. [28] Hay, I.D., Rehman, Z.U., Moradali, M.F., Wang, Y., Rehm, B.H.A., Microbial alginate production, modification and its applications. Microb. Biotechnol 6 (2013), 637–650.
29. [29] Hay, I.D., Wang, Y., Moradali, M.F., Rehman, Z.U., Rehm, B.H., Genetics and regulation of bacterial alginate production. Environ. Microbiol 16 (2014), 2997–3011.
30. [30] Lee, K.Y., Mooney, D.J., Alginate: properties and biomedical applications. Prog. Polym. Sci 37 (2012), 106–126.
31. [31] Lacerda, L., Parize, A.L., Fávere, V., Laranjeira, M.C.M., Stulzer, H.K., Development and evaluation of pH-sensitive sodium alginate/chitosan microparticles containing the antituberculosis drug rifampicin. Mater. Sci. Eng. C Mater. Biol. Appl 39 (2014), 161–167.
32. [32] Onsoyen, E., Commercial applications of alginates. Carbohydr. Eur 14 (1996), 26–31.
33. [33] Brudno, Y., Silva, E.A., Kearney, C.J., Lewin, S.A., Miller, A., Martinick, K.D., et al. Refilling drug delivery depots through the blood. Proc. Natl. Acad. Sci. U.S.A. 111 (2014), 12722–12727.
34. [34] Boekhoven, J., Zha, R.H., Tantakitti, F., Zhuang, E., Zandi, R., Newcomb, C.J., et al. Alginate-peptide amphiphile core-shell microparticles as a targeted drug delivery system. RSC Adv 5 (2015), 8753–8756.
35. [35] Coviello, T., Matricardi, P., Marianecci, C., Alhaique, F., Polysaccharide hydrogels for modified release formulations. J. Control. Release 119 (2007), 5–24.
36. [36] Martin, M.J., Calpena, A.C., Fernandez, F., Mallandrich, M., Galvez, P., Clares, B., Development of alginate microspheres as nystatin carriers for oral mucosa drug delivery. Carbohydr. Polym 117 (2015), 140–149.
37. [37] Mufamadi, M.S., Pillay, V., Choonara, Y.E., Du Toit, L.C., Modi, G., Naidoo, D., et al. A review on composite liposomal technologies for specialized drug delivery. J. Drug Deliv, 2011, 2011, 939851.
38. [38] El-Aassar, M.R., Hafez, E.E., El-Deeb, N.M., Fouda, M.M., Microencapsulation of lectin anti-cancer agent and controlled release by alginate beads, biosafety approach. Int. J. Biol. Macromol 69 (2014), 88–94.
39. [39] Takka, S., Acarturk, F., Calcium alginate microparticles for oral administration: I: effect of sodium alginate type on drug release and drug entrapment efficiency. J. Microencapsul 16 (1999), 275–290.
40. [40] Tonnesen, H.H., Karlsen, J., Alginate in drug delivery systems. Drug Dev. Ind. Pharm 28 (2002), 621–630.
41. [41] Wang, Y., Zhou, J., Qiu, L., Wang, X., Chen, L., Liu, T., et al. Cisplatin-alginate conjugate liposomes for targeted delivery to EGFR-positive ovarian cancer cells. Biomaterials 35 (2014), 4297–4309.
42. [42] Augst, A.D., Kong, H.J., Mooney, D.J., Alginate hydrogels as biomaterials. Macromol. Biosci 6 (2006), 623–633.
43. [43] Bidarra, S.J., Barrias, C.C., Granja, P.L., Injectable alginate hydrogels for cell delivery in tissue engineering. Acta Biomater 10 (2014), 1646–1662.
44. [44] Kim, Y.B., Kim, G.H., PCL/alginate composite scaffolds for hard tissue engineering: fabrication, characterization, and cellular activities. ACS Comb. Sci 17 (2015), 87–99.
45. [45] Quinlan, E., Lopez-Noriega, A., Thompson, E., Kelly, H.M., Cryan, S.A., O'Brien, F.J., Development of collagen-hydroxyapatite scaffolds incorporating PLGA and alginate microparticles for the controlled delivery of rhBMP-2 for bone tissue engineering. J. Control. Release 198 (2015), 71–79.
46. [46] Zheng, L., Jiang, X., Chen, X., Fan, H., Zhang, X., Evaluation of novel in situ synthesized nano-hydroxyapatite/collagen/alginate hydrogels for osteochondral tissue engineering. Biomed. Mater, 9, 2014, 065004.
47. [47] Morris, E.R., Nishinari, K., Rinaudo, M., Gelation of gellan–A review. Food Hydrocolloids 28 (2012), 373–411.
48. [48] Osmałek, T., Froelich, A., Tasarek, S., Application of gellan gum in pharmacy and medicine. Int. J. Pharm 466 (2014), 328–340.
49. [49] Bajaj, I.B., Survase, S.A., Saudagar, P.S., Singhal, R.S., Gellan gum: fermentative production, downstream processing and applications. Food Technol. Biotechnol, 45, 2007, 341.
50. [50] D'Arrigo, G., Di Meo, C., Gaucci, E., Chichiarelli, S., Coviello, T., Capitani, D., et al. Self-assembled gellan-based nanohydrogels as a tool for prednisolone delivery. Soft Matter 8 (2012), 11557–11564.
51. [51] D'Arrigo, G., Navarro, G., Di Meo, C., Matricardi, P., Torchilin, V., Gellan gum nanohydrogel containing anti-inflammatory and anti-cancer drugs: a multi-drug delivery system for a combination therapy in cancer treatment. Eur. J. Pharm. Biopharm 87 (2014), 208–216.
52. [52] Tayel, S.A., El-Nabarawi, M.A., Tadros, M.I., Abd-Elsalam, W.H., Promising ion-sensitive in situ ocular nanoemulsion gels of terbinafine hydrochloride: design, in vitro characterization and in vivo estimation of the ocular irritation and drug pharmacokinetics in the aqueous humor of rabbits. Int. J. Pharm 443 (2013), 293–305.
53. [53] Balasubramaniam, J., Kant, S., Pandit, J.K., In vitro and in vivo evaluation of Gelrite® gellan gum-based ocular delivery system for indomethacin. Acta Pharm 53 (2003), 251–262.
54. [54] Cao, S., Ren, X., Zhang, Q., Chen, E., Xu, F., Chen, J., et al. In situ gel based on gellan gum as new carrier for nasal administration of mometasone furoate. Int. J. Pharm 365 (2009), 109–115.
55. + 3 ion cross-linked and acetalated gellan hydrogel network beads for prolonged release of glipizide. Carbohydr. Polym 85 (2011), 164–172.
56. [56] Saindane, N.S., Pagar, K.P., Vavia, P.R., Nanosuspension based in situ gelling nasal spray of carvedilol: development, in vitro and in vivo characterization. AAPS PharmSciTech 14 (2013), 189–199.
57. [57] Kulkarni, R.V., Mangond, B.S., Mutalik, S., Sa, B., Interpenetrating polymer network microcapsules of gellan gum and egg albumin entrapped with diltiazem–resin complex for controlled release application. Carbohydr. Polym 83 (2011), 1001–1007.
58. [58] Shiyani, B., Gattani, S., Surana, S., Formulation and evaluation of bi-layer tablet of Metoclopramide hydrochloride and Ibuprofen. AAPS PharmSciTech 9 (2008), 818–827.
59. [59] Gohel, M., Parikh, R., Nagori, S., Shah, S., Dabhi, M., Preparation and evaluation of soft gellan gum gel containing paracetamol. Indian J. Pharm. Sci, 71, 2009, 120.
60. [60] Adamsons, I., Clineschmidt, C., Polis, A., Taylor, J., Shedden, A., Laibovitz, R., The efficacy and safety of dorzolamide as adjunctive therapy to timolol maleate gellan solution in patients with elevated intraocular pressure. J. Glaucoma 7 (1998), 247–260.
61. [61] El-Kamel, A., Al-Dosari, H., Al-Jenoobi, F., Environmentally responsive ophthalmic gel formulation of carteolol hydrochloride. Drug Deliv 13 (2006), 55–59.
62. [62] Goyal, R., Tripathi, S., Tyagi, S., Ravi Ram, K., Ansari, K., Shukla, Y., et al. Gellan gum blended PEI nanocomposites as gene delivery agents: evidences from in vitro and in vivo studies. Eur. J. Pharm. Biopharm 79 (2011), 3–14.
63. [63] Cerqueira, M.T., da Silva, L.P., Santos, T.C., Pirraco, R.P., Correlo, V.M., Marques, A.P., et al. Human skin cell fractions fail to self-organize within a gellan gum/hyaluronic acid matrix but positively influence early wound healing. Tissue Eng. Part A 20 (2014), 1369–1378.
64. [64] Pereira, D.R., Canadas, R.F., Silva-Correia, J., Marques, A.P., Reis, R.L., Oliveira, J.M., Gellan gum-based hydrogel bilayered scaffolds for osteochondral tissue engineering. Key Eng. Mater 587 (2014), 255–260.
65. [65] Gantar, A., da Silva, L.P., Oliveira, J.M., Marques, A.P., Correlo, V.M., Novak, S., et al. Nanoparticulate bioactive-glass-reinforced gellan-gum hydrogels for bone-tissue engineering. Mater. Sci. Eng. C Mater. Biol. Appl 43 (2014), 27–36.
66. [66] Rosalam, S., England, R., Review of xanthan gum production from unmodified starches by Xanthomonas comprestris sp. Enzyme Microb. Technol 39 (2006), 197–207.
67. [67] Luo, Y., Wang, Q., Recent development of chitosan-based polyelectrolyte complexes with natural polysaccharides for drug delivery. Int. J. Biol. Macromol 64 (2014), 353–367.
68. [68] Jani, G.K., Shah, D.P., Prajapati, V.D., Gums and mucilages: versatile excipients for pharmaceutical formulations. Asian J. Pharm. Sci, 2009, 308–322.
69. [69] Pooja, D., Panyaram, S., Kulhari, H., Rachamalla, S.S., Sistla, R., Xanthan gum stabilized gold nanoparticles: characterization, biocompatibility, stability and cytotoxicity. Carbohydr. Polym 110 (2014), 1–9.
70. [70] Benny, I.S., Gunasekar, V., Ponnusami, V., Review on application of Xanthan gum in drug delivery. Int. J. PharmTech. Res 6 (2014), 1322–1326.
71. [71] Talukdar, M.M., Plaizier-Vercammen, J., Evaluation of Xanthan cum as a hydrophilic matrix for controlled-release dosage form preparations. Drug Dev. Ind. Pharm 19 (1993), 1037–1046.
72. [72] Xue, D., Sethi, R., Viscoelastic gels of guar and xanthan gum mixtures provide long-term stabilization of iron micro- and nanoparticles. J. Nanopart. Res 14 (2012), 1–14.
73. [73] Manca, M.L., Manconi, M., Valenti, D., Lai, F., Loy, G., Matricardi, P., et al. Liposomes coated with chitosan-xanthan gum (chitosomes) as potential carriers for pulmonary delivery of rifampicin. J. Pharm. Sci 101 (2012), 566–575.
74. [74] Shinde, U.A., Kanojiya, S.S., Serratiopeptidase niosomal gel with potential in topical delivery. J. Pharm. (Cairo), 2014, 2014, 9.
75. [75] Maiti, S., Kaity, S., Ray, S., Sa, B., Development and evaluation of xanthan gum-facilitated ethyl cellulose microsponges for controlled percutaneous delivery of diclofenac sodium. Acta Pharm 61 (2011), 257–270.
76. [76] Verhoeven, E., Vervaet, C., Remon, J.P., Xanthan gum to tailor drug release of sustained-release ethylcellulose mini-matrices prepared via hot-melt extrusion: in vitro and in vivo evaluation. Eur. J. Pharm. Biopharm 63 (2006), 320–330.
77. [77] Jackson, C., Ofoefule, S., Use of Xanthan gum and ethylcellulose in formulation of metronidazole for colon delivery. J. Chem. Pharm. Res 3 (2011), 11–20.
78. [78] Maity, S., Sa, B., Ca-carboxymethyl xanthan gum mini-matrices: swelling, erosion and their impact on drug release mechanism. Int. J. Biol. Macromol 68 (2014), 78–85.
79. [79] Maiti, S., Mukherjee, S., Controlled drug delivery attributes of co-polymer micelles and xanthan-O-carboxymethyl hydrogel particles. Int. J. Biol. Macromol 70 (2014), 37–43.
80. [80] Bacakova, L., Novotna, K., Parizek, M., Polysaccharides as cell carriers for tissue engineering: the use of cellulose in vascular wall reconstruction. Physiol. Res 63:Suppl. 1 (2014), S29–S47.
81. [81] Koop, H.S., de Freitas, R.A., de Souza, M.M., Savi, R. Jr., Silveira, J.L., Topical curcumin-loaded hydrogels obtained using galactomannan from Schizolobium parahybae and xanthan. Carbohydr. Polym 116 (2015), 229–236.
82. [82] Dyondi, D., Webster, T.J., Banerjee, R., A nanoparticulate injectable hydrogel as a tissue engineering scaffold for multiple growth factor delivery for bone regeneration. Int. J. Nanomedicine 8 (2013), 47–59.
83. [83] Izawa, H., Nishino, S., Maeda, H., Morita, K., Ifuku, S., Morimoto, M., et al. Mineralization of hydroxyapatite upon a unique xanthan gum hydrogel by an alternate soaking process. Carbohydr. Polym 102 (2014), 846–851.
84. [84] Kuo, S.M., Chang, S.J., Wang, H.Y., Tang, S.C., Yang, S.W., Evaluation of the ability of xanthan gum/gellan gum/hyaluronan hydrogel membranes to prevent the adhesion of postrepaired tendons. Carbohydr. Polym 114 (2014), 230–237.
85. [85] Nair, L.S., Laurencin, C.T., Polymers as biomaterials for tissue engineering and controlled drug delivery. Adv. Biochem. Eng. Biotechnol 102 (2006), 47–90.
86. [86] Ashiuchi, M., Microbial production and chemical transformation of poly-gamma-glutamate. Microb. Biotechnol 6 (2013), 664–674.
87. [87] Pereira, C.L., Antunes, J.C., Gonçalves, R.M., Ferreira-da-Silva, F., Barbosa, M.A., Biosynthesis of highly pure poly-γ-glutamic acid for biomedical applications. J. Mater. Sci. Mater. Med 23 (2012), 1583–1591.
88. [88] Heng, P.W., Chan, L.W., Wong, T.W., Formation of alginate microspheres produced using emulsification technique. J. Microencapsul 20 (2003), 401–413.
89. [89] Fang, J., Zhang, Y., Yan, S., Liu, Z., He, S., Cui, L., et al. Poly(L-glutamic acid)/chitosan polyelectrolyte complex porous microspheres as cell microcarriers for cartilage regeneration. Acta Biomater 10 (2014), 276–288.
90. [90] Bajaj, I., Singhal, R., Poly (glutamic acid)–an emerging biopolymer of commercial interest. Bioresour. Technol 102 (2011), 5551–5561.
91. [91] Tsai, W.-B., Lai, H.-Y., Lee, J.-L., Lo, C.-W., Chen, W.-S., Enhancement of the cytotoxicity and selectivity of doxorubicin to hepatoma cells by synergistic combination of galactose-decorated γ-poly (glutamic acid) nanoparticles and low-intensity ultrasound. Langmuir 30:19 (2014), 5510–5517.
92. [92] Maya, S., Sarmento, B., Lakshmanan, V.K., Menon, D., Jayakumar, R., Actively targeted cetuximab conjugated gamma-poly(glutamic acid)-docetaxel nanomedicines for epidermal growth factor receptor over expressing colon cancer cells. J. Biomed. Nanotechnol 10 (2014), 1416–1428.
93. [93] Papadimitriou, S.A., Achilias, D.S., Bikiaris, D.N., Chitosan-g-PEG nanoparticles ionically crosslinked with poly (glutamic acid) and tripolyphosphate as protein delivery systems. Int. J. Pharm 430 (2012), 318–327.
94. [94] Du, F., Meng, H., Xu, K., Xu, Y., Luo, P., Luo, Y., et al. CPT loaded nanoparticles based on beta-cyclodextrin-grafted poly (ethylene glycol)/poly (L-glutamic acid) diblock copolymer and their inclusion complexes with CPT. Colloids Surf. B Biointerfaces 113 (2014), 230–236.
95. [95] Toita, R., Nakao, K., Mahara, A., Yamaoka, T., Akashi, M., Biodistribution of vaccines comprised of hydrophobically-modified poly(γ-glutamic acid) nanoparticles and antigen proteins using fluorescence imaging. Bioorg. Med. Chem 21 (2013), 6608–6615.
96. [96] Mokhtarzadeh, A., Parhiz, H., Hashemi, M., Ayatollahi, S., Abnous, K., Ramezani, M., Targeted gene delivery to MCF-7 cells using peptide-conjugated polyethylenimine. AAPS PharmSciTech 16 (2015), 1025–1032.
97. [97] Kurosaki, T., Kitahara, T., Kawakami, S., Higuchi, Y., Yamaguchi, A., Nakagawa, H., et al. Gamma-polyglutamic acid-coated vectors for effective and safe gene therapy. J. Control. Release 142 (2010), 404–410.
98. [98] Hattori, Y., Nakamura, A., Arai, S., Nishigaki, M., Ohkura, H., Kawano, K., et al. In vivo siRNA delivery system for targeting to the liver by poly-l-glutamic acid-coated lipoplex. Results Pharma Sci 4 (2014), 1–7.
99. [99] Shu, X., Shi, Q., Feng, J., Xie, X., Chen, Y., Design and in vitro evaluation of novel γ-PGA/hydroxyapatite nanocomposites for bone tissue engineering. J. Mater. Sci 49 (2014), 7742–7749.
100. [100] Pandey, A.K., Kumar, A., Improved microbial biosynthesis strategies and multifarious applications of the natural biopolymer epsilon-poly-l-lysine. Process Biochem 49 (2014), 496–505.
101. [101] Sasaki, H., Karasawa, K., Hironaka, K., Tahara, K., Tozuka, Y., Takeuchi, H., Retinal drug delivery using eyedrop preparations of poly-L-lysine-modified liposomes. Eur. J. Pharm. Biopharm 83 (2013), 364–369.
102. [102] Yang, B., Lv, Y., Zhu, J.Y., Han, Y.T., Jia, H.Z., Chen, W.H., et al. A pH-responsive drug nanovehicle constructed by reversible attachment of cholesterol to PEGylated poly(l-lysine) via catechol-boronic acid ester formation. Acta Biomater 10 (2014), 3686–3695.
103. [103] Yan, Y., Li, J., Zheng, J., Pan, Y., Wang, J., He, X., et al. Poly (l-lysine)-based star-block copolymers as pH-responsive nanocarriers for anionic drugs. Colloids Surf. B Biointerfaces 95 (2012), 137–143.
104. [104] Yan, Y., Wei, D., Li, J., Zheng, J., Shi, G., Luo, W., et al. A poly (l-lysine)-based hydrophilic star block co-polymer as a protein nanocarrier with facile encapsulation and pH-responsive release. Acta Biomater 8 (2012), 2113–2120.
105. [105] Guo, J., Cheng, W.P., Gu, J., Ding, C., Qu, X., Yang, Z., et al. Systemic delivery of therapeutic small interfering RNA using a pH-triggered amphiphilic poly-L-lysine nanocarrier to suppress prostate cancer growth in mice. Eur. J. Pharm. Sci 45 (2012), 521–532.
106. [106] Sallam, A., Steinbuchel, A., Dipeptides in nutrition and therapy: cyanophycin-derived dipeptides as natural alternatives and their biotechnological production. Appl. Microbiol. Biotechnol 87 (2010), 815–828.
107. [107] Mooibroek, H., Oosterhuis, N., Giuseppin, M., Toonen, M., Franssen, H., Scott, E., et al. Assessment of technological options and economical feasibility for cyanophycin biopolymer and high-value amino acid production. Appl. Microbiol. Biotechnol 77 (2007), 257–267.
108. [108] Matsumura, Y., Hamaguchi, T., Ura, T., Muro, K., Yamada, Y., Shimada, Y., et al. Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin. Br. J. Cancer 91 (2004), 1775–1781.
109. [109] Zheng, Y., Yang, W., Wang, C., Hu, J., Fu, S., Dong, L., et al. Nanoparticles based on the complex of chitosan and polyaspartic acid sodium salt: preparation, characterization and the use for 5-fluorouracil delivery. Eur. J. Pharm. Biopharm 67 (2007), 621–631.
110. [110] Nita, L.E., Chiriac, A., Bercea, M., Wolf, B.A., Synergistic behavior of poly(aspartic acid) and Pluronic F127 in aqueous solution as studied by viscometry and dynamic light scattering. Colloids Surf. B Biointerfaces 103 (2013), 544–549.
111. [111] Oh, N.M., Oh, K.T., Youn, Y.S., Lee, D.K., Cha, K.H., Lee, D.H., et al. Poly(L-aspartic acid) nanogels for lysosome-selective antitumor drug delivery. Colloids Surf. B Biointerfaces 101 (2013), 298–306.
112. [112] Cai, K., Yao, K., Hou, X., Wang, Y., Hou, Y., Yang, Z., et al. Improvement of the functions of osteoblasts seeded on modified poly(D,L-lactic acid) with poly(aspartic acid). J. Biomed. Mater. Res 62 (2002), 283–291.
113. [113] Averous, L., Pollet, E., Biodegradable Polymers, Environmental Silicate Nano- Biocomposites. 2012, Springer.
114. [114] Park, S.J., Kim, T.W., Kim, M.K., Lee, S.Y., Lim, S.C., Advanced bacterial polyhydroxyalkanoates: towards a versatile and sustainable platform for unnatural tailor-made polyesters. Biotechnol. Adv 30 (2012), 1196–1206.
115. [115] Leong, Y.K., Show, P.L., Ooi, C.W., Ling, T.C., Lan, J.C., Current trends in polyhydroxyalkanoates (PHAs) biosynthesis: insights from the recombinant Escherichia coli. J. Biotechnol 180 (2014), 52–65.
116. [116] Chen, G.Q., A microbial polyhydroxyalkanoates (PHA) based bio- and materials industry. Chem. Soc. Rev 38 (2009), 2434–2446.
117. [117] Wang, Z., Itoh, Y., Hosaka, Y., Kobayashi, I., Nakano, Y., Maeda, I., et al. Mechanism of enhancement effect of dendrimer on transdermal drug permeation through polyhydroxyalkanoate matrix. J. Biosci. Bioeng 96 (2003), 537–540.
118. [118] Gref, R., Minamitake, Y., Peracchia, M.T., Trubetskoy, V., Torchilin, V., Langer, R., Biodegradable long-circulating polymeric nanospheres. Science 263 (1994), 1600–1603.
119. [119] Shah, M., Naseer, M.I., Choi, M.H., Kim, M.O., Yoon, S.C., Amphiphilic PHA-mPEG copolymeric nanocontainers for drug delivery: preparation, characterization and in vitro evaluation. Int. J. Pharm 400 (2010), 165–175.
120. [120] Wu, Q., Wang, Y., Chen, G.Q., Medical application of microbial biopolyesters polyhydroxyalkanoates. Artif. Cells Blood Substit. Immobil. Biotechnol 37 (2009), 1–12.
121. [121] Masood, F., Yasin, T., Hameed, A., Polyhydroxyalkanoates – what are the uses? Current challenges and perspectives. Crit. Rev. Biotechnol, 2014, 1–8, 10.3109/07388551.2014.913548.
122. [122] Fu, P., Sodian, R., Luders, C., Lemke, T., Kraemer, L., Hubler, M., et al. Effects of basic fibroblast growth factor and transforming growth factor-beta on maturation of human pediatric aortic cell culture for tissue engineering of cardiovascular structures. ASAIO J. 50 (2004), 9–14.
123. [123] Zhu, X.H., Gan, S.K., Wang, C.-H., Tong, Y.W., Proteins combination on PHBV microsphere scaffold to regulate Hep3B cells activity and functionality: a model of liver tissue engineering system. J. Biomed. Mater. Res. A 83A (2007), 606–616.
124. [124] Baek, J.-Y., Xing, Z.-C., Kwak, G., Yoon, K.-B., Park, S.-Y., Park, L.S., et al. Fabrication and Characterization of Collagen-Immobilized Porous PHBV/HA Nanocomposite Scaffolds for Bone Tissue Engineering. J. Nanomater, 2012, 2012, 11.
125. [125] Li, C., Zhang, J., Li, Y., Moran, S., Khang, G., Ge, Z., Poly (l-lactide-co-caprolactone) scaffolds enhanced with poly (beta-hydroxybutyrate-co-beta-hydroxyvalerate) microspheres for cartilage regeneration. Biomed. Mater, 8, 2013, 025005.
126. [126] Kuppan, P., Vasanthan, K.S., Sundaramurthi, D., Krishnan, U.M., Sethuraman, S., Development of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) fibers for skin tissue engineering: effects of topography, mechanical, and chemical stimuli. Biomacromolecules 12 (2011), 3156–3165.
127. [127] Yucel, D., Kose, G.T., Hasirci, V., Polyester based nerve guidance conduit design. Biomaterials 31 (2010), 1596–1603.